Generics Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I'rom Holdings (IH) to acquire up to 100% of the outstanding shares of its subsidiary I'rom Pharmaceutical. The transaction, financial terms of which are not being disclosed, is being handled via Lupin's Japanese subsidiary Kyowa Pharmaceuticals, which it acquired in 2007, and is aimed at providing entry into Japan's injectable generics market. 18 November 2011